Follow the ETHEMA HEALTH Corp stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €773k. The latest transaction was disclosed on 22 November 2024 (Acquisition). Among the most active insiders: Greene Eileen Maria. All data is free.
6
Insider Decl.
n/a
Thresholds
€850,424
6 ops.
Buy Volume
n/a
n/a
Sell Volume
29Σ signal
Buys €850,424n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,179 of 28,799 companies
10.2
score / 100
Value
14
Quality
7
FCF yld-40%
Earn yld·
EV/EBITDA20.3x
ROE·
Gross mgn·
Net mgn-12%
Debt/EBITDA19.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
10,005,000 shares@ US$0.00040.4% of flowCommon StockSEC:0001903596-24-000383:0
Canonical exit: 3 Sept 2024 (T+90)
6 of 6 declarations
About ETHEMA HEALTH Corp
ETHEMA HEALTH Corp is a publicly traded company on NASDAQ, focused on the healthcare sector. It specializes in developing innovative solutions to enhance patient care.